Lv5
830 积分 2024-08-07 加入
Ianalumab plus Eltrombopag in Immune Thrombocytopenia
3小时前
待确认
Addition of Ianalumab (VAY736) to Ibrutinib in Patients with Chronic Lymphocytic Leukemia on Ibrutinib Therapy: Results from a Phase Ib Study
4小时前
已完结
Bevacizumab for Intravitreal Injection: Impact of Sub-Visible Particles on the Shelf-Life of Repackaged Bevacizumab
12天前
已完结
CD64+ fibroblast-targeted vilanterol and a STING agonist augment CLDN18.2 BiTEs efficacy against pancreatic cancer by reducing desmoplasia and enriching stem-like CD8+ T cells
23天前
已完结
CD64+ fibroblast-targeted vilanterol and a STING agonist augment CLDN18.2 BiTEs efficacy against pancreatic cancer by reducing desmoplasia and enriching stem-like CD8+ T cells
23天前
已完结
Fibroblast heterogeneity in 2025
23天前
已完结
The dawn of ‘off-the-shelf’ B cell-depleting therapies for autoimmune diseases
23天前
已完结
Risk of Alzheimer Disease and Vascular Dementia in Patients With Peripheral Vestibular Disorders
1个月前
已完结
CD19 CAR T-Cell Therapy in Multidrug-Resistant Ulcerative Colitis
4个月前
已关闭
The safety and efficacy of rituximab in autoimmune hepatitis: a systematic review and quality assessment
4个月前
已关闭
[Autosomal dominant intellectual disability-40 caused by a de novo mutation of the CHAMP1 gene: a case report]
皖公网安备34019202002308
